CADL
Candel Therapeutics Inc.
Company Overview
| Mkt Cap | $307.41M | Price | $5.38 |
| Volume | 837.42K | Change | -3.58% |
| P/E Ratio | -5.6 | Open | $5.59 |
| Revenue | -- | Prev Close | $5.58 |
| Net Income | $-55.2M | 52W Range | $3.79 - $14.60 |
| Div Yield | N/A | Target | $20.17 |
| Overall | 43 | Value | 60 |
| Quality | 31 | Technical | 40 |
No chart data available
Stock Overview
Updated DailyCandel Therapeutics Inc. (CADL) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $5.38 with a market capitalization of $307.41 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows CADL with a volume of 837K shares. The stock opened up 0.18% from yesterday's close of $5.58. Current analyst estimates project earnings of $-0.4 per share for this year, with next year targeting $-0.48.
CADL demonstrates weak technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CADL include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 274.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CADL | $5.38 | -3.6% | 837.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Candel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW